The Research of the Development of the Hubei Manufacturing Enterprises in SME Board

As in recent years the deepening reform and opening-up and the accelerated economic development of Hubei region as well as the vigorously advocate of the government for innovation and enterpreneurship,small and medium-sized manufacturing enterprises have already becoming a nucleus of pushing the rapid economic development in Hubei.This paper explores the whole development status of the Hubei Manufacturing Enterprises in SME Board through the analysis of eight aspects of the 186 Hubei Manufacturing Enterprises in SME Board Regularly Operated and Annual Report Disclosure in 2017,which finds out that currently Hubei Manufacturing Enterprises in SME Board concentrate to the developed region,the overall education background of the employees is low and most of the enterprises are private enterprises with labor-intensive economy,the financial situation reflects the characteristics of industry differences.Enterprises should accelerate upgrading and transformation,enhancing the market competitive ability,at the same time the government should carefully study,formulating encouraging and supporting policies suitable for different enterprises and industries,strengthening supervision and management of SME board market in order to attract more outstanding small and medium-sized manufacturing enterprises,accelerating the development of manufacturing industry in Hubei.

基于三阶段DEA的创业板和中小板公司效率研究——以医药制造业为例

运用DEA方法对比研究创业板和中小板公司的效率问题.为了削弱创业板和中小板这一环境因素对效率值的干扰,采用了三阶段DEA方法将收盘价、涨跌幅及成交量作为环境变量,同时以医药制造业公司为例验证了3个环境变量对公司效率的显著影响.结果表明,环境因素对公司效率有显著影响.其中,涨跌幅和收盘价对公司效率有消极影响,而成交量对公司效率的影响有双向作用,其对总资产和资产负债率有积极影响,对员工人数和主营业务成本有消极影响.

医药制造业科创板上市企业的专利信息披露问题研究

本文以截至2023年3月31日申请科创板上市的96家医药制造业企业为研究对象,调研了企业在招股说明书中披露专利的情况,发现了医药制造业企业专利信息披露中存在的问题,并提出建议。研究发现:绝大部分企业均在招股书中披露了其全部授权专利,而没有披露处于审查中的专利申请;约三分之一的企业,其专利完全来自于自主研发;将近一半的企业,其发明专利占比在80%以上;绝大部分企业将一个同族专利在不同国家的授权都计入其所拥有的有效专利总数;所有企业在专利布局时都保护了3个以上的技术主题类型。基于目前企业披露的情况,发现医药制造业企业在披露专利申请、专利与主营业务的对应情况、海外同族专利、专利链接制度参与状态等方面存在问题。